Determination of chlorzoxazone and 6-hydroxychlorzoxazone in human plasma and urine by high-performance liquid chromatography

J Chromatogr B Biomed Appl. 1996 Nov 15;686(2):291-6. doi: 10.1016/s0378-4347(96)00227-7.

Abstract

A sensitive and reproducible method is described for the determination of the cytochrome P450 enzyme 2E1 substrate chlorzoxazone and its primary metabolite 6-hydroxychlorzoxazone in human plasma and urine. Plasma or diluted urine were acidified, incubated with beta-glucuronidase and then were extracted with diethyl ether. Separation of the analytes was achieved on a C18 column with UV detection set at 283 nm. Excellent linearity was observed over the concentration ranges of 100-3000 ng/ml and 4-400 micrograms/ml in plasma and urine, respectively. The intra-assay variability was < or = 5.1% and the inter-assay variability was < or = 8.2% for each compound in each matrix. The method presented is applicable to pharmacokinetic and pharmacogenetic studies utilizing chlorzoxazone.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Chlorzoxazone / analogs & derivatives*
  • Chlorzoxazone / analysis*
  • Chlorzoxazone / blood
  • Chlorzoxazone / urine
  • Chromatography, High Pressure Liquid / methods*
  • Humans
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Spectrophotometry, Ultraviolet

Substances

  • 6-hydroxychlorzoxazone
  • Chlorzoxazone